Brain Advance Access originally published online on April 8, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 6, 1252-1270,
June 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg143
Review Article |
Cannabis and the brain
Department of Pharmacology, University of Oxford, Oxford, UK
Correspondence to: Leslie Iversen, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK E-mail: les.iversen{at}pharm.ox.ac.uk
The active compound in herbal cannabis, 
9-tetrahydrocannabinol, exerts all of its known central effects through the CB1 cannabinoid receptor. Research on cannabinoid mechanisms has been facilitated by the availability of selective antagonists acting at CB1 receptors and the generation of CB1 receptor knockout mice. Particularly important classes of neurons that express high levels of CB1 receptors are GABAergic interneurons in hippocampus, amygdala and cerebral cortex, which also contain the neuropeptides cholecystokinin. Activation of CB1 receptors leads to inhibition of the release of amino acid and monoamine neurotransmitters. The lipid derivatives anandamide and 2-arachidonylglycerol act as endogenous ligands for CB1 receptors (endocannabinoids). They may act as retrograde synaptic mediators of the phenomena of depolarization-induced suppression of inhibition or excitation in hippocampus and cerebellum. Central effects of cannabinoids include disruption of psychomotor behaviour, short-term memory impairment, intoxication, stimulation of appetite, antinociceptive actions (particularly against pain of neuropathic origin) and anti-emetic effects. Although there are signs of mild cognitive impairment in chronic cannabis users there is little evidence that such impairments are irreversible, or that they are accompanied by drug-induced neuropathology. A proportion of regular users of cannabis develop tolerance and dependence on the drug. Some studies have linked chronic use of cannabis with an increased risk of psychiatric illness, but there is little evidence for any causal link. The potential medical applications of cannabis in the treatment of painful muscle spasms and other symptoms of multiple sclerosis are currently being tested in clinical trials. Medicines based on drugs that enhance the function of endocannabinoids may offer novel therapeutic approaches in the future.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Bartholomew, S. Holroyd, and T. M Heffernan Does cannabis use affect prospective memory in young adults? J Psychopharmacol, February 1, 2010; 24(2): 241 - 246. [Abstract] [PDF]
|
|
|
|
 |
|
 H. A Yassa, A. E. W. A Dawood, M. M Shehata, R. H Abdel-Hady, and K. M Abdel Aal Subchronic toxicity of cannabis leaves on male albino rats Human and Experimental Toxicology, January 1, 2010; 29(1): 37 - 47. [Abstract] [PDF]
|
|
|
|
 |
|
 M. T. Compton, M. E. Kelley, C. E. Ramsay, M. Pringle, S. M. Goulding, M. L. Esterberg, T. Stewart, and E. F. Walker Association of Pre-Onset Cannabis, Alcohol, and Tobacco Use With Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients Am J Psychiatry, November 1, 2009; 166(11): 1251 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Taber and R. A. Hurley Endocannabinoids: Stress, Anxiety, and Fear J Neuropsychiatry Clin Neurosci, May 1, 2009; 21(2): iv - 113. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marinelli, S. Pacioni, T. Bisogno, V. Di Marzo, D. A. Prince, J. R. Huguenard, and A. Bacci The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons J. Neurosci., December 10, 2008; 28(50): 13532 - 13541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Lin, S.-C. Mao, P.-S. Chen, and P.-W. Gean Chronic cannabinoid administration in vivo compromises extinction of fear memory Learn. Mem., December 2, 2008; 15(12): 876 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. L. de Win, G. Jager, J. Booij, L. Reneman, T. Schilt, C. Lavini, S. D. Olabarriaga, N. F. Ramsey, G. J. d. Heeten, and W. van den Brink Neurotoxic effects of ecstasy on the thalamus The British Journal of Psychiatry, October 1, 2008; 193(4): 289 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yucel, N. Solowij, C. Respondek, S. Whittle, A. Fornito, C. Pantelis, and D. I. Lubman Regional Brain Abnormalities Associated With Long-term Heavy Cannabis Use Arch Gen Psychiatry, June 1, 2008; 65(6): 694 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Van Laere, M. Koole, S. M. Sanabria Bohorquez, K. Goffin, I. Guenther, M. J. Belanger, J. Cote, P. Rothenberg, I. De Lepeleire, I. D. Grachev, et al. Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects J. Nucl. Med., March 1, 2008; 49(3): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Papathanasopoulos, L. Messinis, E. Lyros, A. Kastellakis, and G. Panagis Multiple Sclerosis, Cannabinoids, and Cognition J Neuropsychiatry Clin Neurosci, February 1, 2008; 20(1): 36 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Bambico, N. Katz, G. Debonnel, and G. Gobbi Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex J. Neurosci., October 24, 2007; 27(43): 11700 - 11711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chang and E. P. Chronicle Functional Imaging Studies in Cannabis Users Neuroscientist, October 1, 2007; 13(5): 422 - 432. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Knapska, K. Radwanska, T. Werka, and L. Kaczmarek Functional Internal Complexity of Amygdala: Focus on Gene Activity Mapping After Behavioral Training and Drugs of Abuse Physiol Rev, October 1, 2007; 87(4): 1113 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Centonze, M. Bari, S. Rossi, C. Prosperetti, R. Furlan, F. Fezza, V. De Chiara, L. Battistini, G. Bernardi, S. Bernardini, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis Brain, October 1, 2007; 130(10): 2543 - 2553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Burns, K. Van Laere, S. Sanabria-Bohorquez, T. G. Hamill, G. Bormans, W.-s. Eng, R. Gibson, C. Ryan, B. Connolly, S. Patel, et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor PNAS, June 5, 2007; 104(23): 9800 - 9805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tappe-Theodor, N. Agarwal, I. Katona, T. Rubino, L. Martini, J. Swiercz, K. Mackie, H. Monyer, D. Parolaro, J. Whistler, et al. A Molecular Basis of Analgesic Tolerance to Cannabinoids J. Neurosci., April 11, 2007; 27(15): 4165 - 4177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Hill, T. Gallopin, I. Ferezou, B. Cauli, J. Rossier, P. Schweitzer, and B. Lambolez Functional CB1 Receptors Are Broadly Expressed in Neocortical GABAergic and Glutamatergic Neurons J Neurophysiol, April 1, 2007; 97(4): 2580 - 2589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bowling Cannabinoids in MS--are we any closer to knowing how best to use them? Multiple Sclerosis, September 1, 2006; 12(5): 523 - 525. [PDF]
|
|
|
|
 |
|
 H. Wang, S. K. Dey, and M. Maccarrone Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility Endocr. Rev., August 1, 2006; 27(5): 427 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Quickfall and D. Crockford Brain Neuroimaging in Cannabis Use: A Review J Neuropsychiatry Clin Neurosci, August 1, 2006; 18(3): 318 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P A McArdle Cannabis use by children and young people. Arch. Dis. Child., August 1, 2006; 91(8): 692 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gobbi, F. R. Bambico, R. Mangieri, M. Bortolato, P. Campolongo, M. Solinas, T. Cassano, M. G. Morgese, G. Debonnel, A. Duranti, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis PNAS, December 20, 2005; 102(51): 18620 - 18625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Di, C. Boudaba, I. R. Popescu, F.-J. Weng, C. Harris, V. L. Marcheselli, N. G. Bazan, and J. G. Tasker Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus J. Physiol., December 15, 2005; 569(3): 751 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Thompson, J. P. Y. Kao, R. H. Kramer, K. E. Poskanzer, R. A. Silver, D. Digregorio, and S. S.-H. Wang Flashy Science: Controlling Neural Function with Light J. Neurosci., November 9, 2005; 25(45): 10358 - 10365. [Full Text] [PDF]
|
|
|
|
|
|
T. Heinbockel, D. H. Brager, C. G. Reich, J. Zhao, S. Muralidharan, B. E. Alger, and J. P. Y. Kao Endocannabinoid Signaling Dynamics Probed with Optical Tools J. Neurosci., October 12, 2005; 25(41): 9449 - 9459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Sipe, N. Arbour, A. Gerber, and E. Beutler Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders J. Leukoc. Biol., July 1, 2005; 78(1): 231 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Boyd and B. A. Fremming Rimonabant--A Selective CB1 Antagonist Ann. Pharmacother., April 1, 2005; 39(4): 684 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Samuels Update in Neurology Ann Intern Med, January 4, 2005; 142(1): 28 - 36. [Full Text] [PDF]
|
|
|
|
|
|
K. Soderstrom, Q. Tian, M. Valenti, and V. Di Marzo Endocannabinoids Link Feeding State and Auditory Perception-Related Gene Expression J. Neurosci., November 3, 2004; 24(44): 10013 - 10021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J H Allen, G M de Moore, R Heddle, and J C Twartz Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse Gut, November 1, 2004; 53(11): 1566 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chaturvedi Cannabis as a psychotropic medication The British Journal of Psychiatry, July 1, 2004; 185(1): 78 - 78. [Full Text] [PDF]
|
|
|
|
 |
|
 Actions and Effects of Cannabis on the Brain Journal Watch Neurology, September 25, 2003; 2003(925): 3 - 3. [Full Text]
|
|